| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute limb ischemia in a patient with Covid-19 pneumonia: a case report
|
Kartikasari, Ulfah
|
|
|
52 |
3 |
p. 974-979
|
artikel
|
| 2 |
A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer
|
Li, Shuangping
|
|
|
52 |
3 |
p. 898-903
|
artikel
|
| 3 |
Association between plasmatic oxidative stress and thrombosis in primary antiphospholipid syndrome
|
Vaz, Camila O.
|
|
|
52 |
3 |
p. 730-737
|
artikel
|
| 4 |
Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice
|
Jongejan, Yvonne K.
|
|
|
52 |
3 |
p. 715-719
|
artikel
|
| 5 |
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor’s page series
|
Becker, Richard C.
|
|
|
52 |
3 |
p. 692-707
|
artikel
|
| 6 |
Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients?
|
As, Ahmet Kagan
|
|
|
52 |
3 |
p. 759-765
|
artikel
|
| 7 |
Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction
|
Abo-Aly, Mohamed
|
|
|
52 |
3 |
p. 934-940
|
artikel
|
| 8 |
CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
|
Gunduz, Ramazan
|
|
|
52 |
3 |
p. 914-924
|
artikel
|
| 9 |
Clinical characteristics and outcomes of splenic infarction in cancer patients: a retrospective, single center report of 206 cases
|
Bewersdorf, Jan Philipp
|
|
|
52 |
3 |
p. 854-862
|
artikel
|
| 10 |
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19
|
Mennuni, Marco G.
|
|
|
52 |
3 |
p. 782-790
|
artikel
|
| 11 |
Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
|
Hormese, Mary
|
|
|
52 |
3 |
p. 828-835
|
artikel
|
| 12 |
Correction to: Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?
|
Siegel, Patrick Malcolm
|
|
|
52 |
3 |
p. 981
|
artikel
|
| 13 |
Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation
|
Grandone, Elvira
|
|
|
52 |
3 |
p. 980
|
artikel
|
| 14 |
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
|
Maier, Cheryl L.
|
|
|
52 |
3 |
p. 766-771
|
artikel
|
| 15 |
Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE)
|
Zhang, Xin
|
|
|
52 |
3 |
p. 863-871
|
artikel
|
| 16 |
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension
|
Porres-Aguilar, Mateo
|
|
|
52 |
3 |
p. 791-796
|
artikel
|
| 17 |
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial
|
Verdoia, M.
|
|
|
52 |
3 |
p. 797-807
|
artikel
|
| 18 |
Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma
|
Bravo-Perez, C.
|
|
|
52 |
3 |
p. 848-853
|
artikel
|
| 19 |
HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia
|
Bauman, Megan M. J.
|
|
|
52 |
3 |
p. 952-961
|
artikel
|
| 20 |
Immature platelets in patients with Covid-19: association with disease severity
|
Cohen, Amir
|
|
|
52 |
3 |
p. 708-714
|
artikel
|
| 21 |
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19
|
Mennuni, Marco G.
|
|
|
52 |
3 |
p. 746-753
|
artikel
|
| 22 |
LncRNA LSINCT5/miR-222 regulates myocardial ischemia‑reperfusion injury through PI3K/AKT pathway
|
Tong, Xueying
|
|
|
52 |
3 |
p. 720-729
|
artikel
|
| 23 |
Monitoring the therapeutic effect of caplacizumab by von Willebrand Factor activity assays: Proceed with caution
|
Yates, Sean G.
|
|
|
52 |
3 |
p. 949-951
|
artikel
|
| 24 |
Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients
|
Muthiah, Mark D.
|
|
|
52 |
3 |
p. 925-933
|
artikel
|
| 25 |
Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic
|
Cope, Rebecca
|
|
|
52 |
3 |
p. 754-758
|
artikel
|
| 26 |
Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
|
Marchandot, Benjamin
|
|
|
52 |
3 |
p. 689-691
|
artikel
|
| 27 |
Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis
|
Nisly, Sarah A.
|
|
|
52 |
3 |
p. 817-827
|
artikel
|
| 28 |
Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore
|
Porfidia, Angelo
|
|
|
52 |
3 |
p. 779-781
|
artikel
|
| 29 |
Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure
|
Chen, Yuyi
|
|
|
52 |
3 |
p. 872-879
|
artikel
|
| 30 |
Stroke and presence of patent foramen ovale in sickle cell disease
|
Aggeli, Constantina
|
|
|
52 |
3 |
p. 889-897
|
artikel
|
| 31 |
ST-segment elevation in patients with COVID-19: a systematic review
|
Diaz-Arocutipa, Carlos
|
|
|
52 |
3 |
p. 738-745
|
artikel
|
| 32 |
Study on the activity of recombinant mutant tissue-type plasminogen activator fused with the C-terminal fragment of hirudin
|
Ren, Keyun
|
|
|
52 |
3 |
p. 880-888
|
artikel
|
| 33 |
SUPPORT‐AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF
|
Sadiq, Hammad
|
|
|
52 |
3 |
p. 808-816
|
artikel
|
| 34 |
The allergic myocardial infarction dilemma: is it the anaphylaxis or the epinephrine?
|
Tan, Pei Zheng
|
|
|
52 |
3 |
p. 941-948
|
artikel
|
| 35 |
The efficacy and safety of direct oral anticoagulants plus aspirin in symptomatic lower extremity peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials
|
Costa, Gonçalo
|
|
|
52 |
3 |
p. 904-913
|
artikel
|
| 36 |
The outcomes of three-factor prothrombin complex concentrate (3F-PCC) in warfarin anticoagulation reversal: a prospective, single-arm, open-label, multicentre study
|
Koh, Hock Peng
|
|
|
52 |
3 |
p. 836-847
|
artikel
|
| 37 |
The relation between acute intracerebral hemorrhage and diffusion-weighted imaging lesions: a meta-analysis
|
Li, Xiang
|
|
|
52 |
3 |
p. 962-970
|
artikel
|
| 38 |
Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation
|
Grandone, Elvira
|
|
|
52 |
3 |
p. 772-778
|
artikel
|
| 39 |
Utility of a recurrence prediction tool (DASH score) at a single centre after unprovoked venous thromboembolism: patient uptake of the tool and short term risks of stopping anticoagulation
|
Thomas, W.
|
|
|
52 |
3 |
p. 971-973
|
artikel
|
Tijdschrift beschrijving